Haukeland University Hospital Release: Pilot Study Shows Promise for Treatment of Pancreatic Cancer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICAGO--(BUSINESS WIRE)--Tiny gas microbubbles may enhance the delivery and absorption of cancer drugs in patients with advanced pancreatic cancer, according to a pilot study described today at the International Contrast Ultrasound Society (ICUS) annual conference.

“Our early findings suggest that commercially-available ultrasound microbubbles, combined with a standard chemotherapy drug, may prolong survival in pancreatic cancer patients,” according to Dr. Odd Helge Gilja, Head of National Centre of Ultrasound in Gastroenterology at Haukeland University Hospital, Chair of Research at Dept. Of Clinical Medicine at University of Bergen, Norway, and President-Elect of the European Federation of Ultrasound in Medicine and Biology.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC